The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some ...

Market is valued at USD 10.25 Billion in 2024 and is projected to reach a value of USD 610.1 Billion by 2035 at a CAGR ...

Automakers are investing aggressively in digital storytelling, influencer marketing, content-driven campaigns, and immersive ...

Including Michaels acquiring JOANN, top university rankings, and seasonal news from both Whataburger and Spirit Halloween.

By Robert Owusu, FCIB Developing and sustaining professional behaviours is critical to any job success. Employers expect ...

The Department of Public Works and Infrastructure has been allocated R7.6 billion for the 2024/25 financial year. This grows to R7.9 billion in the 2026/27 financial year and R8.3 billion in the ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

Shares of CVS Health Corp. CVS shed 1.79% to $66.37 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX remaining mostly unchanged ...

Shares of CVS Health Corp. CVS advanced 2.67% to $68.14 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.80% to 6,141.02 ...

BioGaia AB (BIOGY) reports robust sales growth in Asia Pacific and adult health segments, while facing challenges with ...